Zheng et al. [23] further characterized the presence of primary central nervous system DLBCL (PCNS-DLBCL) mutations in MYD88 and CD79B as well as DNA methyltransferase (MGMT) methylation. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.